Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myeloproliferative Disorders × Dabigatran × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Venous Thrombosis 3 Pulmonary Embolism 3 Neoplasms 3 Venous Thromboembolism 2 Thrombosis 1 Myeloproliferative Disorders 1

Interventions

Cyclophosphamide 72 fludarabine phosphate 67 Peripheral Blood Stem Cell Transplantation 53 Mycophenolic Acid 48 Whole-Body Irradiation 47 Tacrolimus 43 Busulfan 42 Antilymphocyte Serum 38 fludarabine 36 Cyclosporine 35 Filgrastim 29 Melphalan 27 Methotrexate 25 Radiotherapy 21 Methylprednisolone 17 Cytarabine 17 Sirolimus 14 Cord Blood Stem Cell Transplantation 14 thymoglobulin 13 Granulocyte Colony-Stimulating Factor 13 Etoposide 13 Alemtuzumab 13 Flow Cytometry 12 Azacitidine 12 Cyclosporins 11 Biopsy 10 Psychiatric Rehabilitation 9 ruxolitinib 8 Thiotepa 8 Specimen Handling 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡